test bank for lilley's pharmacology for
canadian health care practice 4th edition by
kara sealock, cydnee seneviratne
,table of contents
chapter 01: nursing practice in canada and drug therapy ....................5
chapter 02: pharmacological principles ............................................ 13
chapter 03: legal and ethical considerations ..................................... 21
chapter 04: patient-focused considerations ...................................... 30
chapter 05: gene therapy and pharmacogenomics............................ 47
chapter 06: medication errors: preventing and responding ............... 51
chapter 07: patient education and drug therapy ............................... 60
chapter 08: over-the-counter drugs and natural health products ...... 69
chapter 09: vitamins and minerals.................................................... 77
chapter 10: principles of drug administration ................................... 86
chapter 11: analgesic drugs ............................................................ 103
chapter 12: general and local anaesthetics ..................................... 116
chapter 13: central nervous system depressants and muscle relaxants
...................................................................................................... 124
chapter 14: central nervous system stimulants and related drugs ... 133
chapter 15: antiepileptic drugs ....................................................... 141
chapter 16: antiparkinsonian drugs ................................................ 150
chapter 17: psychotherapeutic drugs .............................................. 158
chapter 18: substance misuse ......................................................... 171
chapter 19: adrenergic drugs .......................................................... 183
chapter 20: adrenergic-blocking drugs............................................ 196
chapter 21: cholinergic drugs ......................................................... 204
chapter 22: cholinergic-blocking drugs ........................................... 213
chapter 23: antihypertensive drugs ................................................ 221
,chapter 24: antianginal drugs ........................................................ 229
chapter 25: heart failure drugs ....................................................... 242
chapter 26: antidysrhythmic drugs ................................................. 255
chapter 27: coagulation modifier drugs .......................................... 263
chapter 28: antilipemic drugs ......................................................... 271
chapter 29: diuretic drugs .............................................................. 284
chapter 30: fluids and electrolytes .................................................. 292
chapter 31: pituitary drugs ............................................................. 300
chapter 32: thyroid and antithyroid drugs ...................................... 309
chapter 33: antidiabetic drugs ........................................................ 321
chapter 34: adrenal drugs .............................................................. 334
chapter 35: women’s health drugs.................................................. 342
chapter 36: men’s health drugs ...................................................... 355
chapter 37: antihistamines, decongestants, antitussives, and
expectorants .................................................................................. 368
chapter 38: respiratory drugs ......................................................... 376
chapter 39: acid-controlling drugs .................................................. 384
chapter 40: antidiarrheal drugs and laxatives ................................. 393
chapter 41: antiemetic and antinausea drugs ................................. 405
chapter 42: nutritional supplements ............................................... 413
chapter 43: antibiotics part 1: sulfonamides, penicillins,
cephalosporins, macrolides, and tetracyclines ................................ 422
chapter 44: antibiotics part 2: aminoglycosides, fluoroquinolones, and
other drugs .................................................................................... 430
chapter 45: antiviral drugs ............................................................. 439
,chapter 46: antitubercular drugs .................................................... 452
chapter 47: antifungal drugs .......................................................... 460
chapter 48: antimalarial, antiprotozoal, and anthelmintic drugs ..... 473
chapter 49: anti-inflammatory and antigout drugs ......................... 481
chapter 50: immunosuppressant drugs ........................................... 489
chapter 51: immunizing drugs and pandemic preparedness ............ 496
chapter 52: antineoplastic drugs part 1: cancer overview and cell
cycle–specific drugs ........................................................................ 505
chapter 53: antineoplastic drugs part 2: cell cycle–nonspecific and
miscellaneous drugs ....................................................................... 513
chapter 54: biological response–modifying drugs and antirheumatic
drugs ............................................................................................. 522
chapter 55: anemia drugs............................................................... 530
chapter 56: dermatological drugs ................................................... 538
chapter 57: ophthalmic drugs ......................................................... 546
chapter 58: otic drugs .................................................................... 555
,chapter 01: nursing practice in canada and drug therapy
multiple choice
1. which is a judgement about a particular patient’s potential need
or problem?
a. a goal
b. an assessment
c. subjective data
d. a nursing diagnosis
ANS>>d
nursing diagnosis is the phase of the nursing process during which a
clinical judgement is made about how a patient responds to heath
conditions and life processes or vulnerability for that response.
dif: cognitive level: knowledge
2. the patient is to receive oral furosemide (lasix) every day;
however, because the patient is unable to swallow, he cannot take
medication orally, as ordered. the nurse needs to contact the
physician. what type of problem is this?
a. a “right time” problem
b. a “right dose” problem
c. a “right route” problem
,d. a “right medication” problem
ANS>>c
this is a “right route” problem: the nurse cannot assume the route and
must clarify the route with the prescriber. this is not a “right time”
problem because the ordered frequency has not changed. this is not a
“right dose” problem because the dose is not related to an inability to
swallow. this is not a “right medication” problem because the
medication ordered will not change, just the route.
dif: cognitive level: application
3. the nurse has been monitoring the patient’s progress on his new
drug regimen since the first dose and has been documenting signs of
possible adverse effects. what nursing process phase is the nurse
practising?
a. planning
b. evaluation
c. implementation
d. nursing diagnosis
ANS>>b
monitoring the patient’s progress is part of the evaluation phase.
planning, implementation, and nursing diagnosis are not illustrated
by this example.
dif: cognitive level: application
, 4. the nurse is caring for a patient who has been newly diagnosed
with type 1 diabetes mellitus. which statement best illustrates an
outcome criterion for this patient?
a. the patient will follow instructions.
b. the patient will not experience complications.
c. the patient adheres to the new insulin treatment regimen.
d. the patient demonstrates safe insulin self-administration
technique.
ANS>>d
having the patient demonstrate safe insulin self-administration
technique is a specific and measurable outcome criterion. following
instructions and avoiding complications are not specific criteria.
adherence to the new insulin treatment regimen is not objective and
would be difficult to measure.
dif: cognitive level: application
5. which activity best reflects the implementation phase of the
nursing process for the patient who is newly diagnosed with type 1
diabetes mellitus?
a. providing education regarding self-injection technique
b. setting goals and outcome criteria with the patient’s input
c. recording a history of over-the-counter medications used at
home
canadian health care practice 4th edition by
kara sealock, cydnee seneviratne
,table of contents
chapter 01: nursing practice in canada and drug therapy ....................5
chapter 02: pharmacological principles ............................................ 13
chapter 03: legal and ethical considerations ..................................... 21
chapter 04: patient-focused considerations ...................................... 30
chapter 05: gene therapy and pharmacogenomics............................ 47
chapter 06: medication errors: preventing and responding ............... 51
chapter 07: patient education and drug therapy ............................... 60
chapter 08: over-the-counter drugs and natural health products ...... 69
chapter 09: vitamins and minerals.................................................... 77
chapter 10: principles of drug administration ................................... 86
chapter 11: analgesic drugs ............................................................ 103
chapter 12: general and local anaesthetics ..................................... 116
chapter 13: central nervous system depressants and muscle relaxants
...................................................................................................... 124
chapter 14: central nervous system stimulants and related drugs ... 133
chapter 15: antiepileptic drugs ....................................................... 141
chapter 16: antiparkinsonian drugs ................................................ 150
chapter 17: psychotherapeutic drugs .............................................. 158
chapter 18: substance misuse ......................................................... 171
chapter 19: adrenergic drugs .......................................................... 183
chapter 20: adrenergic-blocking drugs............................................ 196
chapter 21: cholinergic drugs ......................................................... 204
chapter 22: cholinergic-blocking drugs ........................................... 213
chapter 23: antihypertensive drugs ................................................ 221
,chapter 24: antianginal drugs ........................................................ 229
chapter 25: heart failure drugs ....................................................... 242
chapter 26: antidysrhythmic drugs ................................................. 255
chapter 27: coagulation modifier drugs .......................................... 263
chapter 28: antilipemic drugs ......................................................... 271
chapter 29: diuretic drugs .............................................................. 284
chapter 30: fluids and electrolytes .................................................. 292
chapter 31: pituitary drugs ............................................................. 300
chapter 32: thyroid and antithyroid drugs ...................................... 309
chapter 33: antidiabetic drugs ........................................................ 321
chapter 34: adrenal drugs .............................................................. 334
chapter 35: women’s health drugs.................................................. 342
chapter 36: men’s health drugs ...................................................... 355
chapter 37: antihistamines, decongestants, antitussives, and
expectorants .................................................................................. 368
chapter 38: respiratory drugs ......................................................... 376
chapter 39: acid-controlling drugs .................................................. 384
chapter 40: antidiarrheal drugs and laxatives ................................. 393
chapter 41: antiemetic and antinausea drugs ................................. 405
chapter 42: nutritional supplements ............................................... 413
chapter 43: antibiotics part 1: sulfonamides, penicillins,
cephalosporins, macrolides, and tetracyclines ................................ 422
chapter 44: antibiotics part 2: aminoglycosides, fluoroquinolones, and
other drugs .................................................................................... 430
chapter 45: antiviral drugs ............................................................. 439
,chapter 46: antitubercular drugs .................................................... 452
chapter 47: antifungal drugs .......................................................... 460
chapter 48: antimalarial, antiprotozoal, and anthelmintic drugs ..... 473
chapter 49: anti-inflammatory and antigout drugs ......................... 481
chapter 50: immunosuppressant drugs ........................................... 489
chapter 51: immunizing drugs and pandemic preparedness ............ 496
chapter 52: antineoplastic drugs part 1: cancer overview and cell
cycle–specific drugs ........................................................................ 505
chapter 53: antineoplastic drugs part 2: cell cycle–nonspecific and
miscellaneous drugs ....................................................................... 513
chapter 54: biological response–modifying drugs and antirheumatic
drugs ............................................................................................. 522
chapter 55: anemia drugs............................................................... 530
chapter 56: dermatological drugs ................................................... 538
chapter 57: ophthalmic drugs ......................................................... 546
chapter 58: otic drugs .................................................................... 555
,chapter 01: nursing practice in canada and drug therapy
multiple choice
1. which is a judgement about a particular patient’s potential need
or problem?
a. a goal
b. an assessment
c. subjective data
d. a nursing diagnosis
ANS>>d
nursing diagnosis is the phase of the nursing process during which a
clinical judgement is made about how a patient responds to heath
conditions and life processes or vulnerability for that response.
dif: cognitive level: knowledge
2. the patient is to receive oral furosemide (lasix) every day;
however, because the patient is unable to swallow, he cannot take
medication orally, as ordered. the nurse needs to contact the
physician. what type of problem is this?
a. a “right time” problem
b. a “right dose” problem
c. a “right route” problem
,d. a “right medication” problem
ANS>>c
this is a “right route” problem: the nurse cannot assume the route and
must clarify the route with the prescriber. this is not a “right time”
problem because the ordered frequency has not changed. this is not a
“right dose” problem because the dose is not related to an inability to
swallow. this is not a “right medication” problem because the
medication ordered will not change, just the route.
dif: cognitive level: application
3. the nurse has been monitoring the patient’s progress on his new
drug regimen since the first dose and has been documenting signs of
possible adverse effects. what nursing process phase is the nurse
practising?
a. planning
b. evaluation
c. implementation
d. nursing diagnosis
ANS>>b
monitoring the patient’s progress is part of the evaluation phase.
planning, implementation, and nursing diagnosis are not illustrated
by this example.
dif: cognitive level: application
, 4. the nurse is caring for a patient who has been newly diagnosed
with type 1 diabetes mellitus. which statement best illustrates an
outcome criterion for this patient?
a. the patient will follow instructions.
b. the patient will not experience complications.
c. the patient adheres to the new insulin treatment regimen.
d. the patient demonstrates safe insulin self-administration
technique.
ANS>>d
having the patient demonstrate safe insulin self-administration
technique is a specific and measurable outcome criterion. following
instructions and avoiding complications are not specific criteria.
adherence to the new insulin treatment regimen is not objective and
would be difficult to measure.
dif: cognitive level: application
5. which activity best reflects the implementation phase of the
nursing process for the patient who is newly diagnosed with type 1
diabetes mellitus?
a. providing education regarding self-injection technique
b. setting goals and outcome criteria with the patient’s input
c. recording a history of over-the-counter medications used at
home
